Delivering drugs to gut tumors can be tricky. Researchers at Washington University in St. Louis have engineered an oral ...
After Seelos Therapeutics’ amyotrophic lateral sclerosis (ALS) candidate failed a phase 2/3 study, the biotech has filed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback